Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
DE000A11QVV0
Thu, 28.08.2025       Heidelberg Pharma AG

Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx FDA has requested additional data relating to the Chemistry, Manufacturing, and Controls (CMC) package Expected payment of USD 70 million from HealthCare Royalty to Heidelberg Pharma will be delayed Current cash reach until Q1 2026 Ladenbu [ … ]
Thu, 13.03.2025       Heidelberg Pharma AG

Ad hoc announcement - Disclosure of inside information under Article 17 of Regulation (EU) No 596/2014 Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty HealthCare Royalty and Heidelberg Pharma amend royalty financing agreement to provide for USD 20 million payment Heidelberg Pharma extends cash runway into 2027 Ladenburg, Ger [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2025 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2025 WEBs Investments ETFs
Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 07.09.2025, Calendar Week 36, 250th day of the year, 115 days remaining until EoY.